期刊文献+

心脏移植围术期辅助循环治疗的初步临床经验 被引量:2

Preliminary clinical experence of perioperative auxiliary circulation in cardiac transplantation
原文传递
导出
摘要 目的 探讨辅助循环治疗应用于心脏移植围术期的临床疗效.方法 回顾性分析山东省千佛山医院2012年7月1日至2017年10月31日13例心脏移植患者围术期应用主动脉内球囊反搏术(IABP)、体外膜肺氧合(ECMO)和连续肾脏替代疗法(CRRT)辅助循环治疗的临床资料,其中应用ECMO 6例(ECMO+ IABP 3例),IABP辅助7例(IABP+ CRRT 1例).根据患者术后存活情况、心功能、肾功能等数据评估辅助循环治疗对心脏移植术后发生移植物功能障碍的治疗效果.结果 6例单独使用IABP者5例成功撤除,1例应用IABP+ CRRT辅助成功,ECMO或ECMO+ IABP辅助者成功率50%,而2例术中安置ECMO+IABP者全部成功.4例死者中,2例患者术中开始应用ECMO辅助,分别于术后第5天死于右心衰竭和术后第7天死于多脏器衰竭,1例受者术后安置ECMO+IABP辅助,术后第11天死于多脏器衰竭,1例IABP辅助者术后第3天发生脑出血于术后第13天死亡.其余患者术后各项功能恢复良好.结论 心脏移植围术期合理应用IABP、ECMO和CRRT辅助循环治疗可作为心脏移植术后低心排、心肌收缩不良等移植物功能障碍的有效治疗手段,但急性排斥反应和器官移植物的衰竭仍需注意. Objective To analyze the application of IABP,ECMO and other auxiliary circulatory treatment cases in the perioperative period of heart transplantation,and summarize the clinical efficacy and application experience.Methods Retrospective analysis was conducted on the clinical data of thirteen patients with cardiac transplantation(IABP,ECMO,etc.)during the perioperative period from July 1,2012 to October 31,2017.There were six ECMO applications(including three cases of ECMO+IABP application)and seven cases of IABP(including one case of IABP+CRRT).The prognosis of heart transplantation was analyzed according to the patient survival rate,cardiac function and renal function.Results Five of the six independent IABP auxiliaries successfully removed IABP.One application of IABP+CRRT assisted success.The success rate of ECMO or ECMO+IABP is 50%.The ECMO+IABP was successfully resettled in nearly 2 cases.Of the four deceased patients,two of them received ECMO assistance during surgery.They died of right heart failure on the fifth postoperative day and multiple organ failure on the seventh postoperative day.One patient received postoperative ECMO+IABP assistance and died of multiple organ failure on the eleventh day after surgery.One IABP-assisted cerebral hemorrhage occurred on the third postoperative day and died on the thirteenth postoperative day.All other patients recovered well after surgery.Conclusion Appropriate application of IABP,ECMO,and other auxiliary circulation therapy during the perioperative period of heart transplantation can improve the success rate of heart transplantation.
作者 乙飞 厉泉 王勇 陈善良 毕严斌 李敏 李培杰 许莉 车东阳 王东 刘天起 Yi Fei;Li Quan;Wang Yong;Chen Shanliang;Bi Yanbin;Li Min;Li Peijie;Xu Li;Che Dongyang;Wang Dong;Liu Tianqi(Weifang Medical College Clinial Medical College,Weifang 261053,China)
出处 《中华心力衰竭和心肌病杂志(中英文)》 2018年第2期90-94,共5页 Chinese Journal of Heart Failure and Cardiomyopathy
关键词 心脏移植 手术期间 辅助循环 Heart transplantation Intraoperative period Assisted circulation
  • 相关文献

参考文献1

二级参考文献17

  • 1张世泽,周思伯,方立德,等.原位心脏移植一例报告[J].上海医学,1978,10:625-627.
  • 2Costanzo M R, Dipchand A, Starling R, et al. The inter- national society of heart and lung transplantation guide- lines for the care of heart transplant recipients [ J ]. J Heart Lung Transplant, 2010, 29(8) :914-956.
  • 3Schaffer J M, Chiu P, Singh S K, et al. Heart and com- bined heart-kidney transplantation in patients with con- comitant renal insufficiency and end-stage heart failure [J]. Am J Transplant, 2014, 14(2) : 384-396.
  • 4Russo M J, Chen J M, Sorabella R A, et al. The effect of ischemic time on survival after heart transplantation va- ries by donor age: an analysis of the United Network for Organ Sharing database [ J ]. J Thorac Cardiovasc Surg, 2007, 133(2) : 554-559.
  • 5John R, Rajasinghe H A, Chen J M, et al. Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy [J]. Ann Thorac Surg, 2001, 72(2): 440-449.
  • 6Rosenberg P B, Vriesendorp A E, Drazner M H, et al. Induction therapy with basiliximab allows delayed initia- tion of cyclosporine and preserves renal function after car- diac transplantation [ J ]. J Heart Lung Transplant, 2005, 24(9) : 1327-1331.
  • 7Aliabadi A, Gr6mmer M, Zuckermann A. Is induction therapy still needed in heart transplantation? [ J ]. Curt Opin Organ Transplant, 2011, 16(5) : 536-542.
  • 8Billingham M E, Cary N R, Hammond M E, et al. A working formulation for the standardization of nomencla- ture in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation [ J ]. J Heart Transplant, 1990, 9 (6) .587.
  • 9Stewart S, Winters G L, Fishbein M C, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection[ J]. J Heart Lung Transplant, 2005, 24( 11 ) : 1710-1720.
  • 10Bamard J B, Thekkudan J, Richardson S, et al. Cyclos-porine profiling with C2 and CO monitoring improves outcomes after heart transplantation [J]. J Heart Lung Transplant, 2006, 25(5): 564-568.

共引文献1

同被引文献33

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部